NotesFAQContact Us
Collection
Advanced
Search Tips
Back to results
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ1225780
Record Type: Journal
Publication Date: 2019-Aug
Pages: 20
Abstractor: As Provided
ISBN: N/A
ISSN: ISSN-0268-1153
EISSN: N/A
Available Date: N/A
Human Papillomavirus Vaccination among Diverse College Students in the State of Georgia: Who Receives Recommendation, Who Initiates and What Are the Reasons?
Vu, Milkie; Bednarczyk, Robert A.; Escoffery, Cam; Getachew, Betelihem; Berg, Carla J.
Health Education Research, v34 n4 p415-434 Aug 2019
Young adulthood is a critical time for catch-up HPV vaccination. We assessed predictors of vaccine recommendation and initiation among college students. We analysed cross-sectional surveys from 2397 students using multivariable logistic regressions. Guided by the Socio-ecological and Health Belief Models, measures included socio-demographic characteristics, intrapersonal measures (e.g. vaccine beliefs), interpersonal measures (e.g. doctor's recommendation) and institutional-level measures (e.g. college settings). The sample included students from private, public, technical and historically black colleges/universities. Of the sample, 64.5% were White; additionally, 48.3% of women (n = 750/1552) and 18.8% of men (n = 159/845) received a doctor's recommendation. Among women, predictors included older age, US-born, higher parental education and attending private schools. Among men, predictors included younger age, being homosexual and attending private schools. HPV vaccine series initiation was low--43.3% of women (n = 672) and 16.7% of men (n = 141). Doctor's recommendation predicted initiation for both sexes. Younger women, women attending technical colleges and men of 'multiple/other' race had lower odds of initiation. Common initiation barriers for both sexes included a lack of doctor recommendation and sexual inactivity. These barriers and the associations between nativity, race and socio-economic status with vaccine recommendation and initiation should be further investigated. Interventions should improve patient-provider communication around HPV vaccine.
Oxford University Press. Great Clarendon Street, Oxford OX2 6DP, UK. Tel: +44-1865-353907; Fax: +44-1865-353485; e-mail: jnls.cust.serv@oxfordjournals.org; Web site: http://her.oxfordjournals.org/
Publication Type: Journal Articles; Reports - Research; Tests/Questionnaires
Education Level: Higher Education; Postsecondary Education
Audience: N/A
Language: English
Sponsor: National Cancer Institute (NCI) (NIH); National Institute of Allergy and Infectious Diseases (NIAID/NIH)
Authoring Institution: N/A
Grant or Contract Numbers: 1R01CA17942201; K01AI106961
Author Affiliations: N/A